Related Experiment Video
Updated: Jul 16, 2026
07:20
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 15, 2011
Plasmid DNA-induced cytokines together with cyclophosphamide decrease size and number of melanoma lung metastases
Tomasz Cichon1, Ryszard Smolarczyk, Aleksander Sochanik
1Department of Molecular Biology, Center of Oncology, Maria Sklodowska-Curie Memorial Institute, 44-101 Gliwice, Poland.
Anticancer Research
|July 11, 2006
Summary
This study combined cyclophosphamide (CTX) with plasmid DNA to induce pro-inflammatory cytokines, enhancing melanoma treatment in mice. This novel approach reduced metastasis size and number, significantly extending survival.
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Cyclophosphamide (CTX) inhibits melanoma metastasis growth but does not reduce metastasis number.
- Targeting remaining metastases requires novel therapeutic strategies.
- Pro-inflammatory cytokines show potential in activating immune cells against cancer.
Purpose of the Study:
- To investigate if local induction of pro-inflammatory cytokines enhances CTX efficacy against B16(F10) melanoma lung metastases.
- To evaluate the combined therapeutic effect of CTX and plasmid DNA-induced cytokines.
- To assess the impact on metastasis size, number, and overall survival.
Main Methods:
- Mice with experimental B16(F10) melanoma lung metastases were treated with CTX.
- Pro-inflammatory cytokines were induced using systemic administration of plasmid DNA-PEl polyplexes.
- Therapeutic effects were assessed by measuring metastasis burden and survival rates.
Main Results:
- The combination therapy significantly reduced both the size and number of melanoma metastases in mouse lungs.
- Plasmid DNA-PEl polyplexes successfully induced pro-inflammatory cytokines, including IL-12, TNF-alpha, IFN-gamma, and IFN-alpha.
- This approach led to a significant extension of survival in treated mice.
Conclusions:
- Combining CTX with plasmid DNA-induced pro-inflammatory cytokines is a promising strategy for treating melanoma lung metastases.
- The induction of cytokines like IFN-alpha activates NK cells, crucial for eliminating metastatic foci.
- This dual approach offers a significant survival benefit and reduces metastasis burden.
